| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/20/2000 | WO2000021561A1 Model and method for angiogenesis inhibition |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021528A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 04/20/2000 | WO2000021524A1 Pufa supplements |
| 04/20/2000 | WO2000021518A1 Drug preparation 'histochrome' for treating ocular conditions |
| 04/20/2000 | WO2000021512A2 Composition and method for treating allergic diseases |
| 04/20/2000 | WO2000005245A3 Inhibitors of urokinase and blood vessel formation |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | WO1999048868A9 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 04/20/2000 | DE19950327A1 Use of carotenoid ester compounds, especially derived from lutein and zeaxanthin, in prevention and treatment of eye disorders, especially age-related macular degeneration and cataract |
| 04/20/2000 | DE19845372A1 Verwendung von Katecholderivaten als Proteinaseninhibitoren Using catechol as proteinase inhibitors |
| 04/20/2000 | CA2653503A1 The use of ara as a supplement for a lactating woman |
| 04/20/2000 | CA2346867A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346542A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 04/20/2000 | CA2346228A1 Composition and method for treating allergic diseases |
| 04/20/2000 | CA2346227A1 Composition and method for treating allergic diseases |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/19/2000 | EP0993457A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | CN1250660A Liquid medicine for treating wound and pain |
| 04/19/2000 | CN1250606A Refreshing sweets for network users |
| 04/18/2000 | US6051712 Piperidine derivatives having renin inhibiting activity |
| 04/18/2000 | US6051573 Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists |
| 04/18/2000 | US6051243 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 04/13/2000 | WO2000020612A2 Therapeutically active proteins in plants |
| 04/13/2000 | WO2000020570A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/13/2000 | WO2000020423A1 Tricyclic δ3-piperidines as pharmaceuticals |
| 04/13/2000 | WO2000020421A2 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020401A1 New bis-benzimidazoles |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020395A1 New crystal modification iii of torasemide |
| 04/13/2000 | WO2000020378A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 04/13/2000 | WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020039A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | WO2000020006A1 Use of diltiazem for treating retinal pathologies |
| 04/13/2000 | WO2000020002A1 Composition for treatment of light-injured retinal degeneration disease |
| 04/13/2000 | WO2000019989A2 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | WO2000019987A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | DE19842416A1 Sekundäre Amine zur Prävention und Therapie von Erkrankungen, die durch Oxidationsprozesse verursacht oder verstärkt werden Secondary amines for the prevention and treatment of diseases that are caused or aggravated by oxidation processes |
| 04/13/2000 | CA2346452A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | CA2346443A1 Prostaglandin receptor ligands |
| 04/13/2000 | CA2346363A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | CA2346086A1 Composition for treatment of light-injured retinal degeneration disease |
| 04/13/2000 | CA2346040A1 New bis-benzimidazoles |
| 04/13/2000 | CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | CA2346034A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | CA2346019A1 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | CA2345808A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | CA2345789A1 New crystal modification iii of torasemide |
| 04/13/2000 | CA2344269A1 Therapeutically active proteins in plants |
| 04/13/2000 | CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 04/12/2000 | EP0991650A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 04/12/2000 | EP0991424A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 04/12/2000 | CN1250484A Diagnosis and treatment of glaucoma |
| 04/12/2000 | CN1250480A Eukaryotic gene expression cassette and uses thereof |
| 04/12/2000 | CN1250369A Method of treating dry eye disease with purinergic receptor agonists |
| 04/11/2000 | US6048896 For treatment of brain or nervous system disorders |
| 04/11/2000 | US6048895 Antagonists of prostaglandin f for treating bone fractures and diseases and glaucoma |
| 04/11/2000 | US6048891 Administering mixtures with 6-hydroxy-2,7,8-trimethyl-chroman-2-propanoic acid for treatment of cardiovascular and kidney disorders |
| 04/11/2000 | US6048873 Skin disorders |
| 04/11/2000 | US6048872 Dietetics; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders |
| 04/11/2000 | US6048855 Topical composition containing capsazepine |
| 04/11/2000 | CA2182086C Use of mometasone furoate for treating airway passage and lung diseases |
| 04/11/2000 | CA2009503C Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO2000018432A1 Carbohydrate vaccines for viral diseases |
| 04/06/2000 | WO2000018424A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 04/06/2000 | WO2000018422A1 Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides |
| 04/06/2000 | WO2000018407A1 Methods for preventing/treating damage to sensory hair cells and cochlear neurons |
| 04/06/2000 | WO2000018404A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018388A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018386A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018353A2 A novel inhibitor of cataract formation |
| 04/06/2000 | WO2000018316A2 Sustained release, and comfortable ophthalmic composition and method for ocular therapy |
| 04/06/2000 | WO2000018230A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | WO2000006588B1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 04/06/2000 | WO1999037294A3 Mitochondria protecting agents for treating mitochondria associated diseases |
| 04/06/2000 | CA2774207A1 Antibiotic compositions for treatment of the eye |
| 04/06/2000 | CA2659064A1 Antibiotic compositions for treatment of the ear and nose |
| 04/06/2000 | CA2346061A1 Carbohydrate vaccines for viral diseases |
| 04/06/2000 | CA2345414A1 Eyedrops for promoting lacrimal secretion or treating keratoconjunctival disorders containing natriuretic peptide as active ingredient |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | CA2344050A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | CA2343098A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | CA2343038A1 A novel inhibitor of cataract formation |
| 04/06/2000 | CA2342603A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/05/2000 | EP0989982A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 04/05/2000 | EP0989972A1 Prostaglandin pharmaceutical compositions |
| 04/05/2000 | EP0989805A1 Nucleic acid sequences for atp-binding cassette transporter |
| 04/05/2000 | EP0766664B1 Metalloproteinase inhibitors |